MedTrace Logo

PONV Prevention Via Percutaneous Nerve Electrical Stimulation on PC6

NCT06241547 · Status: ACTIVE_NOT_RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 302

Last updated 2026-04-13

No results posted yet for this study

Summary

This study aims to certify the effectiveness of percutaneous electrical nerve stimulation at Pericardium 6 (PC6) via a wearable equipment during perioperative period on preventing postoperative nausea and vomiting.

Conditions

  • Postoperative Nausea and Vomiting

Interventions

DEVICE

electrical stimualtion via EmeTerm bracelet

We planned to exert electrical stimulation via the bracelet.

DRUG

antimetic drugs（ dexamethasone，ondansetron）

Antimetic drugs (dexamethasone ondansetron) are used to prevent postoperative nausea and vomiting.

Sponsors & Collaborators

  • Peking Union Medical College Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-01-12
Primary Completion
2026-01-10
Completion
2026-03-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06241547 on ClinicalTrials.gov